192 related articles for article (PubMed ID: 17259336)
1. Insulin-degrading enzyme hydrolyzes ATP.
Del Carmen Camberos M; Cresto JC
Exp Biol Med (Maywood); 2007 Feb; 232(2):281-92. PubMed ID: 17259336
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
Cordes CM; Bennett RG; Siford GL; Hamel FG
Biochem Pharmacol; 2009 Mar; 77(6):1064-73. PubMed ID: 19154729
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the binding of the fluorescent ATP analog TNP-ATP to insulysin.
Yao H; Hersh LB
Arch Biochem Biophys; 2006 Jul; 451(2):175-81. PubMed ID: 16723115
[TBL] [Abstract][Full Text] [Related]
4. The proteolytic activity of insulin-degrading enzyme: a mass spectrometry study.
Grasso G; Rizzarelli E; Spoto G
J Mass Spectrom; 2009 May; 44(5):735-41. PubMed ID: 19127548
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between insulin-degrading enzyme activity and insulin sensitivity in cell model of insulin-resistance].
Li CZ; Zhang SH; Shu CD; Ren W
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):151-4. PubMed ID: 12390813
[TBL] [Abstract][Full Text] [Related]
6. Functional human insulin-degrading enzyme can be expressed in bacteria.
Chesneau V; Rosner MR
Protein Expr Purif; 2000 Jun; 19(1):91-8. PubMed ID: 10833395
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone inhibits insulin binding to insulin-degrading enzyme and cytosolic insulin-binding protein p82.
Harada S; Smith RM; Hu DQ; Jarett L
Biochem Biophys Res Commun; 1996 Jan; 218(1):154-8. PubMed ID: 8573122
[TBL] [Abstract][Full Text] [Related]
8. Insulin acts intracellularly on proteasomes through insulin-degrading enzyme.
Duckworth WC; Bennett RG; Hamel FG
Biochem Biophys Res Commun; 1998 Mar; 244(2):390-4. PubMed ID: 9514933
[TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis of enzymatic hydrolysis of ATP in human and rat blood serum.
Yegutkin GG
Biochemistry (Mosc); 1997 Jun; 62(6):619-22. PubMed ID: 9284543
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
Ciaccio C; Tundo GR; Grasso G; Spoto G; Marasco D; Ruvo M; Gioia M; Rizzarelli E; Coletta M
J Mol Biol; 2009 Feb; 385(5):1556-67. PubMed ID: 19073193
[TBL] [Abstract][Full Text] [Related]
11. Insulin-degrading enzyme.
Authier F; Posner BI; Bergeron JJ
Clin Invest Med; 1996 Jun; 19(3):149-60. PubMed ID: 8724818
[TBL] [Abstract][Full Text] [Related]
12. Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencing.
Fawcett J; Permana PA; Levy JL; Duckworth WC
Arch Biochem Biophys; 2007 Dec; 468(1):128-33. PubMed ID: 17964527
[TBL] [Abstract][Full Text] [Related]
13. Insulin degrading enzyme is localized predominantly at the cell surface of polarized and unpolarized human cerebrovascular endothelial cell cultures.
Lynch JA; George AM; Eisenhauer PB; Conn K; Gao W; Carreras I; Wells JM; McKee A; Ullman MD; Fine RE
J Neurosci Res; 2006 May; 83(7):1262-70. PubMed ID: 16511862
[TBL] [Abstract][Full Text] [Related]
14. ATP inhibits insulin-degrading enzyme activity.
Camberos MC; Pérez AA; Udrisar DP; Wanderley MI; Cresto JC
Exp Biol Med (Maywood); 2001 Apr; 226(4):334-41. PubMed ID: 11368426
[TBL] [Abstract][Full Text] [Related]
15. Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE.
Im H; Manolopoulou M; Malito E; Shen Y; Zhao J; Neant-Fery M; Sun CY; Meredith SC; Sisodia SS; Leissring MA; Tang WJ
J Biol Chem; 2007 Aug; 282(35):25453-63. PubMed ID: 17613531
[TBL] [Abstract][Full Text] [Related]
16. [Insulin degradation in hepatocytes and erythrocytes of rats in normal condition and in experimental diabetes].
Nikolaev SL; Strelkova MA; Komov VP
Vopr Med Khim; 2001; 47(3):329-37. PubMed ID: 11558315
[TBL] [Abstract][Full Text] [Related]
17. Effect of nelfinavir on insulin metabolism, proteasome activity and protein degradation in HepG2 cells.
Hamel FG; Fawcett J; Tsui BT; Bennett RG; Duckworth WC
Diabetes Obes Metab; 2006 Nov; 8(6):661-8. PubMed ID: 17026490
[TBL] [Abstract][Full Text] [Related]
18. Enzyme kinetics from circular dichroism of insulin reveals mechanistic insights into the regulation of insulin-degrading enzyme.
Ivancic VA; Krasinski CA; Zheng Q; Meservier RJ; Spratt DE; Lazo ND
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30305381
[TBL] [Abstract][Full Text] [Related]
19. Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.
Pérez A; Morelli L; Cresto JC; Castaño EM
Neurochem Res; 2000 Feb; 25(2):247-55. PubMed ID: 10786709
[TBL] [Abstract][Full Text] [Related]
20. Degradation of relaxin family peptides by insulin-degrading enzyme.
Bennett RG; Heimann DG; Hamel FG
Ann N Y Acad Sci; 2009 Apr; 1160():38-41. PubMed ID: 19416156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
